| 1975 |
The beta subunit of hemoglobin (HBB) is translated from its mRNA by ribosomes; when alpha-globin synthesis is inhibited, beta-globin synthesis is stimulated, with the rate of elongation increasing more than initiation, indicating that initiation is the rate-limiting step in beta-globin production and that alpha and beta mRNAs compete for limiting translation components. |
Cell-free translation assay with rabbit reticulocytes; inhibition of alpha-chain synthesis with O-methyl-L-threonine; radioactive amino acid incorporation; carboxymethyl cellulose chromatography; SDS-PAGE; tryptic peptide electrophoresis |
European journal of biochemistry |
Medium |
1183442
|
| 1975 |
Alpha- and beta-globin mRNAs are translated with equivalent fidelity and efficiency; proteins associated with polysomal mRNA (mRNP) do not alter the specificity of translation or the requirement for initiation factors, as shown by identical products and efficiencies from mRNP and deproteinized mRNA. |
Cell-free translation of rabbit reticulocyte mRNP and deproteinized mRNA in mouse Krebs II ascites tumor cell system; comparison with and without reticulocyte initiation factors |
Biochimica et biophysica acta |
Medium |
1125229
|
| 1976 |
The hexanucleotide sequence AAUAAA is present ~20 residues upstream of the 3'-terminal poly(A) in beta-globin mRNA (and other eukaryotic mRNAs), identifying this as a conserved polyadenylation signal in the 3' non-coding region of HBB mRNA. |
RNA sequencing of purified alpha- and beta-globin mRNAs from rabbit and human; sequence comparison across six eukaryotic mRNAs |
Nature |
High |
822353
|
| 1978 |
Glucose reacts nonenzymatically with the NH2-terminal amino acid of the beta chain of human hemoglobin (HBB) via a ketoamine linkage, forming hemoglobin A1c; this glycosylation accumulates throughout the 120-day erythrocyte lifespan and is elevated two- to threefold in diabetic patients. |
Biochemical characterization of hemoglobin A1c; identification of ketoamine linkage; measurement in normal and diabetic red cells |
Science |
High |
635569
|
| 1979 |
A splicing region (~500 bp SV40 segment) is required for accumulation of stable beta-globin mRNA in infected monkey cells; without this splicing sequence, a beta-globin recombinant retains the late region promoter but produces neither stable globin transcript nor detectable beta-globin protein. |
SV40-rabbit beta-globin recombinant virus construction; transfection into monkey cells; RNA stability analysis; radioimmunoassay for beta-globin protein |
Cell |
High |
225043
|
| 1980 |
The human beta-globin gene contains two intervening sequences (introns): a small one near the 5' end and a large one (~900 bp) between codons for amino acids 104 and 105; the linked delta-globin gene has a large intervening sequence at the identical coding position but with little sequence homology to the beta-globin intron. |
Molecular cloning from bacteriophage lambda libraries; restriction endonuclease mapping; partial DNA sequencing; hybridization experiments |
Cell |
High |
728996
|
| 1980 |
The complete nucleotide sequence of the human beta-globin gene was determined, including the promoter regions with conserved ATA (~-31 bp) and CCAAT (~-77 bp) sequences upstream of the transcription start site, providing the basis for comparing normal and mutant beta-globin genes. |
DNA sequencing of cloned human beta-globin gene |
Cell |
High |
6254664
|
| 1981 |
The rabbit beta-globin gene produces a colinear pre-mRNA transcript whose 5' and 3' ends map at the same positions as mature mRNA; splicing proceeds via partially spliced intermediates, with the small intervening sequence removed before the large one, demonstrating stepwise splicing of both introns. |
S1 nuclease mapping of RNA from rabbit bone marrow; characterization of splicing intermediates |
Cell |
High |
7471214
|
| 1981 |
The rabbit beta-globin promoter is recognized in Xenopus frog embryos and transcripts are correctly spliced, demonstrating conservation of beta-globin transcription and splicing signals across vertebrates. |
Microinjection of rabbit beta-globin gene into fertilized Xenopus eggs; S1 nuclease mapping of transcripts |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
6946453
|
| 1982 |
Human beta-globin pre-mRNA is accurately spliced in vitro by HeLa whole-cell extracts; the small intervening sequence is removed with correct junction sequence; transcripts terminated upstream of the polyadenylation site are spliced most efficiently, while transcripts terminated downstream are not spliced at all. |
In vitro splicing with HeLa whole-cell extracts; primer extension analysis of splice junctions; comparison of transcripts with different termination points |
Nucleic acids research |
High |
6292841
|
| 1983 |
Beta-globin gene expression is induced 5- to 50-fold upon chemical differentiation of murine erythroleukemia (MEL) cells, with nuclear transcription experiments showing increased transcription rate; the induction is specific to globin genes in an erythroid cell context, and regulatory sequences are conserved between mouse and human. |
Stable transfection of MEL cells; S1 nuclease and primer extension analysis; nuclear transcription run-on assay; chemical induction of differentiation |
Cell |
High |
6572107
|
| 1983 |
The structure of human oxyhaemoglobin was determined at 2.1 Å resolution; the beta subunit HBB iron atom lies 0.00(8) Å from the porphyrin mean plane in the oxy state; the haem is ruffled in the beta subunit; the Fe-O(1) bond length is 1.87(13) Å; HisE7 forms no hydrogen bond (or only weak) to the oxygen in the beta subunit, in contrast to the alpha subunit; C-terminal HisHC3(146 beta) is delocalized and cannot form the intersubunit salt bridges present in deoxyhaemoglobin. |
Single crystal X-ray crystallography at 2.1 Å resolution; Jack-Levitt refinement |
Journal of molecular biology |
High |
6644819
|
| 1984 |
The structure of human deoxyhaemoglobin was refined at 1.74 Å resolution; in the beta haem, the iron is displaced 0.36(5) Å from the porphyrin nitrogen mean plane toward the proximal histidine; the Fe-Nepsilon(F8) bond is 2.12(4) Å; beta haem shows no uniform tilting of pyrrole planes but pyrroles II and IV (eclipsed by His F8) are tilted ~8°; the haem is domed toward the proximal side, consistent with the allosteric T-state mechanism. |
Synchrotron X-ray crystallography at 1.74 Å; crystallographic refinement (R=16.0%) |
Journal of molecular biology |
High |
6726807
|
| 1984 |
The modular promoter structure of the beta-globin gene was defined: elements from the beta-globin ATA box, middle element, and distal element can be functionally exchanged with corresponding elements from the TK promoter; the beta-globin ATA box is required for full activity, as mosaic promoters retaining it are equally active to the wild-type promoter, while those with TK ATA box are 4–10 fold less active. |
Construction of mosaic beta-globin/TK promoters; enhancer-dependent transient expression assay in cell culture |
The EMBO journal |
Medium |
6096121
|
| 1985 |
Erythroid-specific DNase I super-hypersensitive (HS) sites upstream of the human beta-globin locus (the locus control region, LCR) are required for high-level expression of beta-globin genes in transgenic mice; when HS sequences were combined with both gamma- and beta-globin gene fragments, correct developmental switching was restored, suggesting competition among globin genes for interaction with the HS sequences. |
Transgenic mouse experiments; microinjection of constructs containing HS sites fused to individual or combined globin genes; measurement of globin expression and developmental regulation |
Genes & development |
High |
1692558
|
| 1985 |
A thalassemia mutation (IVS2-705) causes beta-globin pre-mRNA missplicing via two aberrant splices in the large intron; introduction of a second mutation into the cryptic 3' splice site at position 580 completely reverses the aberrant splicing and restores normal IVS2 removal, demonstrating that the two abnormal splice events are subtly interdependent. |
Expression of cloned thalassemia beta-globin gene in HeLa cells; oligomer-directed mutagenesis of cryptic splice site; RNA analysis |
The Journal of biological chemistry |
High |
3840804
|
| 1985 |
Human beta-globin genes introduced into transgenic mice with up to 4300 bp of 5'-flanking sequence are expressed in an erythroid-specific manner at levels comparable to endogenous mouse beta-globin; expression is first detected between days 11–14 of development; constructs with as little as 48 bp of 5'-flanking sequence are also expressed appropriately, and the mRNA directs beta-globin protein synthesis in reticulocyte lysates. |
Transgenic mouse production by microinjection; Northern blot and S1 analysis of beta-globin mRNA; reticulocyte lysate in vitro translation; protein detection in mature erythrocytes |
The EMBO journal |
High |
2992937
|
| 1985 |
Sequences 0.5–1.2 kb downstream from the beta-globin poly(A) addition site constitute a transcriptional enhancer element that is erythroid- and developmental stage-specific, demonstrating that the human beta-globin gene contains a downstream cis-regulatory element contributing to its regulated expression. |
Transgenic mouse experiments with constructs containing downstream deletions; reporter gene assays in tissue culture |
Nucleic acids research |
Medium |
3039464
|
| 1986 |
Saturation mutagenesis of the mouse beta-major globin promoter defined three cis-acting regions required for accurate and efficient transcription initiation: (i) the CACCC box (-87 to -95), (ii) the CCAAT box (-72 to -77), and (iii) the TATA box (-26 to -30); mutations in other regions had no effect, while two mutations immediately upstream of the CCAAT box increased transcription 3- to 3.5-fold. |
Saturation mutagenesis (>100 single base substitutions); transient transfection into HeLa cells with SV40 enhancer; measurement of correctly initiated beta-globin transcripts |
Science |
High |
3457470
|
| 1988 |
Nonsense mutations at multiple positions in the human beta-globin gene decrease the steady-state level of beta-globin mRNA in a transfection system; this effect is a general property of premature translation termination codons in beta-globin, not restricted to specific codons or types of nonsense mutations. |
Heterologous transfection of cloned beta-globin genes with five nonsense and two missense mutations; measurement of beta-globin mRNA steady-state levels |
Proceedings of the National Academy of Sciences of the United States of America |
High |
3353367
|
| 1988 |
The chicken beta-globin enhancer stimulates transcription of both beta- and epsilon-globin genes; developmental stage-specific regulation of beta-globin requires interaction between the enhancer and a positive regulatory element (stage selector element, SSE) within the adult beta-globin promoter, as defined by deletion and substitution analysis. |
Deletion and substitution mutant analysis of chicken beta-globin enhancer and promoter elements; transient transfection assays in erythroid cells |
Cell |
High |
3167976
|
| 1989 |
Transcriptionally active extracts from chick red cells support beta-globin transcription in vitro; two proteins—PAL (a repressor, highest in mature red cells) and CON (an activator, highest in actively transcribing cells)—bind adjacent sites in the beta-globin promoter and have opposing effects on transcription; PAL's repression can be overcome by blocking its binding site with a protein with similar recognition sequence but different function. |
In vitro transcription with erythroid cell extracts at different developmental stages; identification of PAL and CON by DNA binding and functional assays |
Cell |
High |
2736626
|
| 1992 |
The beta-39 nonsense mutation causes deficient accumulation of beta-globin mRNA through a defect occurring prior to mRNA accumulation in the cytoplasm (i.e., in the nucleus); mRNA cytoplasmic stability, 3' end processing, and splicing accuracy are normal, and reduced transcription rate fully or partially accounts for the decreased mRNA, suggesting a nuclear/transcriptional mechanism for nonsense-mediated mRNA reduction. |
Transfection into cell lines with temperature-sensitive RNA Pol II; nuclear run-on transcription; mRNA stability analysis; splicing and polyadenylation assays |
Proceedings of the National Academy of Sciences of the United States of America |
High |
1557399
|
| 1993 |
The human beta-globin gene domain contains a single bidirectional replication origin located immediately upstream of the beta-globin gene; this origin is used for DNA synthesis initiation in both expressing and non-expressing cells (which differ in replication timing). Deletion of this origin (as in hemoglobin Lepore syndrome) cancels bidirectional synthesis and reverses replication direction, providing genetic proof of a discrete mammalian replication origin. |
Replication direction assay on >200 kb of the human beta-like globin domain; analysis of hemoglobin Lepore deletion patients |
Nature |
High |
8255298
|
| 1996 |
EKLF (erythroid Krüppel-like factor) binds the beta-globin CACCC box and stabilizes the interaction between the LCR and the beta-globin gene; in EKLF knockout mice, beta-globin transcription is absent with concurrent chromatin structure changes at the beta promoter, and the gamma/beta gene competition ratio is altered, demonstrating EKLF's role in gene competition within the locus. |
EKLF knockout/human beta-locus transgenic compound mice; allele-specific transcription analysis; chromatin structure analysis at beta and gamma promoters |
Genes & development |
High |
8918890
|
| 1997 |
Novel intergenic nuclear transcripts span the LCR and intergenic regions of the human beta-globin locus in erythroid cells; transfection of a beta-globin gene (epsilon, gamma, or beta) induces transcription of the LCR and intergenic regions from the chromosomal locus in nonerythroid cells (transinduction), dependent on transcription of the plasmid-borne globin gene but not protein expression; in situ hybridization shows the plasmid colocalizes with the endogenous locus. |
Nuclear run-on analysis; in situ hybridization; transient transfection in nonerythroid cells; colocalization experiments |
Genes & development |
High |
9334315
|
| 1998 |
EKLF activates the beta-globin promoter through the overall structure of the beta promoter rather than solely through the CACCC box sequence; swapping CACCC boxes between beta and gamma promoters shows that EKLF's specificity is determined by the promoter context, not just the CACCC sequence or its position. |
Transient transfection assays in CV-1 and K562 cells; chimeric beta/gamma promoter constructs with swapped CACCC boxes; EKLF co-transfection |
Molecular and cellular biology |
Medium |
9418858
|
| 1998 |
Trans-splicing group I ribozymes convert sickle beta-globin transcripts into mRNAs encoding anti-sickling gamma-globin in erythrocyte precursors derived from sickle cell disease patients, demonstrating that RNA repair via trans-splicing can alter beta-globin mRNA in primary human cells. |
Group I ribozyme trans-splicing in erythrocyte precursors from sickle cell patients; RT-PCR and sequencing of repaired transcripts |
Science |
Medium |
9616120
|
| 2000 |
Human 5'→3' exonuclease Xrn2 promotes transcriptional termination of the beta-globin gene downstream of the poly(A) signal; co-transcriptional cleavage (CoTC) ~1 kb downstream creates a free 5' RNA end that is degraded by Xrn2, and this degradation induces dissociation of RNA Pol II from the template (torpedo model of termination). |
RNA interference knockdown of Xrn2 in HeLa cells; nuclear run-on assays; analysis of co-transcriptional cleavage activity; characterization of CoTC as autocatalytic RNA structure |
Nature |
High |
15565158
|
| 2001 |
BP1, a homeodomain protein and isoform of DLX4, binds two silencer sequences upstream of the adult human beta-globin gene and represses beta-globin promoter activity in cotransfection assays; BP1 expression decreases upon induction of the beta-globin gene in erythroid cells, and mutation of the -150 CAGTGC binding motif abolishes both BP1 binding and its repressive function. |
cDNA cloning and sequencing; cotransfection assays with beta-globin promoter reporter; gel-shift competition assays; mutagenesis of binding sites |
Molecular and cellular biology |
Medium |
11909945
|
| 2001 |
Nuclear ferritin (ferritin-H enriched) binds specifically to a CAGTGC motif at -153 to -148 bp in the beta-globin promoter; purified ferritin-H and expressed ferritin-H repress beta-globin promoter-driven reporter expression in cotransfected cells when EKLF is present as activator; mutation of the CAGTGC motif reduces binding 20-fold and abrogates ferritin-H repression while retaining EKLF activation. |
Gel-shift/competition assays with K562 nuclear extracts; cotransfection of ferritin-H expression clones with CAT reporter; mutagenesis of CAGTGC motif |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
11481480
|
| 2002 |
In erythroid cells, the LCR hypersensitive sites come into close spatial proximity with the active beta-globin genes, with intervening chromatin (containing inactive genes) looping out; in non-expressing brain tissue, the locus adopts a linear conformation; distant HS regions also participate in these interactions, demonstrating that spatial clustering of regulatory elements creates active chromatin domains. |
Chromosome conformation capture (3C) assay; formaldehyde crosslinking in erythroid and brain cells; analysis of ~200 kb of murine beta-globin locus |
Molecular cell |
High |
12504019
|
| 2003 |
The active chromatin hub (ACH) of the beta-globin locus is developmentally conserved in mice and humans, consisting of LCR HS1-6, upstream 5'HS-60/-62 and 3'HS1; individual globin genes switch their interaction with this core cluster correlating with their transcriptional activity; in committed but not yet expressing erythroid progenitors, only a subset of interactions are stable, and full hub assembly occurs upon differentiation-triggered gene activation. |
3C analysis at multiple developmental stages; comparison of mouse and human loci; analysis in erythroid progenitors and differentiated cells |
Nature genetics |
High |
14517543
|
| 2004 |
Mutations in the 5'UTR of the human beta-globin gene (+10, +22, +33, +40-43) reduce steady-state mRNA to 61–86% of wild-type; nuclear run-on experiments show that mutations +10 and +33 reduce transcription rate, accounting for decreased mRNA, while +22 acts post-transcriptionally; none affect mRNA transport, 3' end processing, or stability. |
Stable transfection of mutant HBB genes in MEL cells with LCR; Northern blot; nuclear run-on; mRNA stability and transport assays |
British journal of haematology |
High |
15009072
|
| 2004 |
In adult murine erythroid cells, the LCR and transcribed beta-globin genes exist within domains of histone acetylation with RNA Pol II; silent embryonic genes lie in hypoacetylated chromatin without Pol II; in human K562 cells, H3/H4 acetylation and H3K4 methylation are continuous over 17 kb including LCR and active epsilon-globin gene, varying directly with transcription, while HeLa cells show H3K9 methylation instead. |
Chromatin immunoprecipitation (ChIP) with real-time PCR; analysis of histone modifications and Pol II across globin locus |
Proceedings of the National Academy of Sciences of the United States of America |
High |
15105444
|
| 2007 |
The MLL2 histone methyltransferase complex associates with the hematopoietic activator NF-E2 in erythroid cells; NF-E2-dependent recruitment of MLL2 to the beta-globin locus is required for H3K4 trimethylation and maximal transcription; MLL2-associated subunit ASH2L is restricted to the LCR while MLL2 itself spreads across the entire beta-globin locus, revealing a mechanism for activator-directed H3K4 methylation at a distance. |
Co-immunoprecipitation of MLL2 complex with NF-E2; ChIP during erythroid differentiation; NF-E2 knockdown; mass spectrometry identification of complex components |
Molecular cell |
High |
17707229
|
| 2007 |
Beta-globin intergenic transcription and histone H3 acetylation/K4 methylation in sequences between HS2 and the epsilon-globin gene require an intact HS2 enhancer that recruits RNA Pol II; Pol II recruitment at HS2 and intergenic modifications are not sufficient for target gene transcription, which additionally requires initiation at the gene's own TATA box, demonstrating that intergenic and genic transcription complexes are independent. |
Minichromosome system with HS2-epsilon-globin; ChIP for Pol II and histone modifications; TATA box mutations; HS2 enhancer mutations |
Molecular and cellular biology |
High |
17283048
|
| 2008 |
GATA-1 binding at LCR HS2 directly recruits CBP histone acetyltransferase and RNA Pol II to HS2; loss of GATA-1 at HS2 severely reduces epsilon-globin transcription with loss of Pol II from the transcription start site and reduction of H3 acetylation and H3K4 di/tri-methylation in coding sequences, while H3K4 mono-methylation remains unaffected. |
Minichromosome with mutated GATA-1 sites in HS2; ChIP for CBP, Pol II, and histone modifications; RNAi knockdown of NF-E2; DNase I hypersensitivity assay |
Nucleic acids research |
High |
18586828
|
| 2010 |
PRMT1-mediated asymmetric dimethylation of H4R3 at the beta-globin locus facilitates histone H3 acetylation on Lys9/Lys14 by providing a binding surface for PCAF; dimethyl H4R3 directly enhances H3 acetylation in vitro; PRMT1 knockdown prevents H3 acetylation, LCR-promoter interaction, and recruitment of transcription preinitiation complexes, blocking beta-globin transcription and erythroid differentiation. |
PRMT1 RNAi knockdown and rescue with rat PRMT1; ChIP for H4R3me2 and H3 acetylation; in vitro acetylation assay; 3C for LCR-promoter interaction; Pol II ChIP |
Blood |
High |
20068219
|
| 2010 |
Ldb1 stabilizes its erythroid partners (SCL, GATA-1, LMO2) on beta-globin chromatin and is required for enrichment of P-TEFb (which phosphorylates Ser2 of RNA Pol II CTD for elongation); Ldb1 reduction prevents locus migration from the nuclear periphery to transcription factories, implicating nuclear relocalization as a critical step for robust beta-globin transcription. |
Ldb1 knockdown; ChIP for erythroid complex components and P-TEFb; nuclear localization by FISH; differentiation assays |
Blood |
High |
20570862
|
| 2011 |
Upon erythroid differentiation, cohesin and its loading factor Nipbl bind the beta-globin LCR, CTCF insulator elements, and the specific activated globin gene; Nipbl-dependent cohesin binding is required for long-range chromatin interactions between CTCF insulators and between the LCR distal enhancer and the target gene, and these interactions are necessary for globin gene expression. |
ChIP for cohesin and Nipbl during differentiation; 3C for chromatin interactions; Nipbl heterozygous mouse model; loss-of-function assays in cell culture |
The Journal of biological chemistry |
High |
21454523
|
| 2015 |
Splicing promotes the nuclear export of beta-globin mRNA by overcoming an active nuclear retention element present in the mRNA; unspliced cDNA-derived beta-globin mRNA is retained in the nucleus and degraded, and this retention can be overcome by increasing mRNA length or by splicing, indicating a default export pathway opposed by specific nuclear retention sequences in HBB mRNA. |
Reporter constructs with beta-globin sequences in HeLa cells; nuclear/cytoplasmic fractionation; analysis of spliced vs. intronless beta-globin mRNA; length-dependence experiments |
RNA |
Medium |
26362019
|
| 2016 |
The beta subunit of hemoglobin (HBB) acts as a lung-derived antimetastatic factor; a C-terminal peptide (Metox) mediates growth arrest and apoptosis of neuroblastoma and other cancer cell lines; HBB2 is produced by alveolar epithelial and endothelial cells in mice and is upregulated in mice bearing clinically undetectable metastasis. |
Peptide mapping; in vitro cell viability and apoptosis assays; in vivo xenograft and spontaneous metastasis mouse models; expression studies by immunohistochemistry and ELISA |
Cancer research |
Medium |
27793844
|
| 2020 |
Decreased beta-globin expression (modeled by CRISPR-Cas9 knockout) induces robust re-expression of gamma-globin in differentiating erythroid precursors; ATF4 binds within the HBS1L-MYB intergenic enhancer to regulate MYB expression; reduced ATF4 upon beta-globin knockout decreases MYB and BCL11A levels, identifying ATF4 as a regulator of stress-induced gamma-globin compensation. |
CRISPR-Cas9 knockout of HBB in isogenic erythroid precursors; RNA-seq; ChIP-seq for ATF4 binding; functional knockdown of ATF4 |
Cell reports |
High |
32755585
|
| 2023 |
LncRNA16 binds to HBB protein and promotes HBB accumulation by inhibiting autophagy; lncRNA16 functions as a scaffold facilitating colocalization of HBB and NDUFAF5 in mitochondria; HBB/NDUFAF5 axis inhibits ROS generation, and this pathway contributes to chemoresistance in non-small cell lung cancer. |
ChIRP-MS (comprehensive identification of RNA-binding proteins by mass spectrometry); RNA immunoprecipitation (RIP); RNA pull-down; immunohistochemistry; mouse chemoresistance models; GalNAc-siRNA targeting |
Science China. Life sciences |
Medium |
38155279
|
| 2000 |
Human Upf proteins (hUpf1, hUpf2, hUpf3a, hUpf3b) are required for nonsense-mediated decay (NMD) of beta-globin mRNA containing premature termination codons; hUpf3a and hUpf3b associate selectively with spliced beta-globin mRNA in vivo, and tethering any hUpf protein to the 3'UTR of beta-globin mRNA elicits NMD, establishing that exon-exon junctions downstream of a termination codon mark mRNA for decay. |
Co-immunoprecipitation; tethering assay with beta-globin mRNA 3'UTR reporters; subcellular localization by microscopy; in vivo mRNA association assays |
Cell |
High |
11163187
|